Seeds of power: China turns to genetic engineering to become global superpower

Amid persistent US-China tensions and recurring supply chain shocks, Beijing is moving upstream in the food system by tightening control over seed genetics through both hybrid breeding systems and genetically modified (GM) technologies. The objective is to narrow yield gaps with advanced economies like the US and reduce import dependence, particularly on feed and food crops like corn and soybean.

Advanced seed biotechnology — including precision trait engineering, transgenic development and gene editing — remains dominated by a small number of multinational firms: Bayer, Corteva, ChemChina’s Syngenta Group and BASF collectively control roughly 50-60% of the global seed market. Despite substantial domestic investment, China continues to lag — and this is the chokehold Beijing seeks to break.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

China’s seed strategy ultimately reflects a broader effort to transform agricultural productivity into a domain of technological and geopolitical competition, where genetic innovation becomes as consequential as commodity trade. As this system evolves, seeds, instruments of food production, will become increasingly strategic assets shaping the future architecture of global agriculture.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
Screenshot 2026-05-11 at 11.30
Despite politicized disinformation, Midwest AI data centers are fueling a solar energy boom
Screenshot-2026-05-08-at-11.55.47-AM
Anti-vax activists falsely blame COVID vaccines for the rising U.S. cancer rate among younger people.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.